Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB08875_nanopub.RAPmYHdclWvA9kGoRQlMc3AM_tUtyOp3iq5r7JCDJYfJ4#assertion>. }
Showing items 1 to 17 of
17
with 100 items per page.
- drugbank:DB08875 type drugbank_vocabulary:Drug assertion.
- drugbank:DB08875 label "Cabozantinib [drugbank:DB08875]" assertion.
- drugbank:DB08875 seeAlso cometriq-drug.htm assertion.
- drugbank:DB08875 seeAlso cabozantinib.html assertion.
- drugbank:DB08875 seeAlso DB08875 assertion.
- drugbank:DB08875 description "Cabozantinib was approved in 2012 and is a non-specific tyrosine kinase inhibitor. It is marketed as COMETRIQâ¢, which is indicated for the treatment of metastatic medullary thyroid cancer. It's label includes a black box warning of gastrointestinal perforations, fistulas, and hemorrhage." assertion.
- drugbank:DB08875 identifier "drugbank:DB08875" assertion.
- drugbank:DB08875 title "Cabozantinib" assertion.
- drugbank:DB08875 drugbank_vocabulary:x-cas cas:849217-68-1 assertion.
- drugbank:DB08875 drugbank_vocabulary:drugbank-id "DB08875" assertion.
- drugbank:DB08875 bio2rdf_vocabulary:x-identifiers.org DB08875 assertion.
- drugbank:DB08875 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08875" assertion.
- drugbank:DB08875 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB08875 bio2rdf_vocabulary:identifier "DB08875" assertion.
- drugbank:DB08875 drugbank_vocabulary:x-wikipedia wikipedia:Cabozantinib assertion.
- drugbank:DB08875 drugbank_vocabulary:x-kegg kegg:D10062 assertion.
- drugbank:DB08875 drugbank_vocabulary:x-chebi chebi:72317 assertion.